Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1983Liver International

Hepatitis B virus replication and clinical outcome in carriers of HBsAg. Perspectives of treatment with DNA inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

FBFerruccio BoninoIstituto di Fisiologia ClinicaSRS. RecchiaUniversity of NottinghamPFPatrizia FarciNational Institute of Allergy and Infectious Diseases

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bonino et al. (1983) studied this question.

synapsesocial.com/papers/6a93b2e680e39a190d56ba40https://doi.org/10.1111/j.1600-0676.1983.tb00847.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The δ agent: HBsAg particles with δ antigen and RNA in the serum of an HBV carrier1981 · 78 citations
  2. 2Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.1977 · 1,020 citations